Results of Operations and Financial Condition. On August 6, 2026, Natera, Inc. issued a press release announcing the results for its second quarter ended June 30, 2026 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the accompan…

Director — Monica Bertagnolli: Ms. Bertagnolli resigned due to her new position with the National Academy of Medicine.

Director — Thomas Lynch: Dr. Thomas Lynch was appointed as a new Class I director and joined the Human Capital Committee.

The filing describes an amendment to the equity incentive plan, not a management change.

Director — Thomas Lynch: Dr. Thomas Lynch was appointed as a new Class I director and joined the Human Capital Committee.

Results of Operations and Financial Condition. On May 7, 2026 , Natera, Inc. issued a press release announcing the results for its first quarter ended March 31, 2026 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the accompanyi…

Director — Eric Rubin: Dr. Eric Rubin was appointed as a new Class I director of Natera, Inc.

Results of Operations and Financial Condition. On February 26, 2026, Natera, Inc. issued a press release announcing the results for its fourth quarter and year ended December 31, 2025 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K…

Results of Operations and Financial Condition. On January 11, 2026, Natera, Inc. (the “Company”) issued a press release announcing preliminary financial results for its fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in this Current Report on Form 8-K and the accompanying Exhibit 99.1 shall not be deemed “filed” for purposes of Sect…

Other Events. On December 5, 2025, the Company issued a press release announcing its acquisition of Foresight. A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. Forward-Looking Statements All statements other than statements of historical facts contained in this Current Report on Form 8-K are forward-looking statements and are not a representation that the Company’s plans, estimates, or expectations will be a…

Unregistered Sales of Equity Securities. On December 4, 2025, Natera, Inc. (the “Company”) acquired Foresight Diagnostics Inc. (“Foresight”), a privately held cancer diagnostics company and Clinical Laboratory Improvement Amendments-registered laboratory that specializes in molecular residual disease detection in B-cell lymphomas, pursuant to that certain Agreement and Plan of Merger, dated as of October 10, 2025, by and among the Company, Falcon Acquisition Sub, Inc., a wholly owned subsidia…

Results of Operations and Financial Condition. On November 6, 2025, Natera, Inc. issued a press release announcing the results for its third quarter ended September 30, 2025 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the ac…

Results of Operations and Financial Condition. On August 7, 2025, Natera, Inc. issued a press release announcing the results for its second quarter ended June 30, 2025 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the accompan…

The filing describes an equity plan amendment and is not related to a management change.

Results of Operations and Financial Condition. On May 8, 2025, Natera, Inc. issued a press release announcing the results for its first quarter ended March 31, 2025 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the accompanyin…

Results of Operations and Financial Condition. On February 27, 2025, Natera, Inc. issued a press release announcing the results for its fourth quarter and year ended December 31, 2024 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K…

Results of Operations and Financial Condition. On January 12, 2025, Natera, Inc. (the “Company”) issued a press release announcing preliminary financial results for its fourth quarter and fiscal year ended December 31, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in this Current Report on Form 8-K and the accompanying Exhibit 99.1 shall not be deemed “filed” for purposes of Sect…

Executive Chairman and Co-Founder — Matthew Rabinowitz, Ph.D.: Amended and Restated Employment Agreement was entered into, continuing Dr. Rabinowitz's role as Executive Chairman with updated compensation terms.

Results of Operations and Financial Condition. On November 12, 2024, Natera, Inc. issued a press release announcing the results for its third quarter ended September 30, 2024 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the a…

Results of Operations and Financial Condition. On August 8, 2024, Natera, Inc. issued a press release announcing the results for its second quarter ended June 30, 2024 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the accompan…

Other Events. On July 19, 2024, Natera, Inc. (the “Company”) elected to exercise its optional redemption right to redeem all $287,500,000 aggregate principal amount of its outstanding 2.25% Convertible Senior Notes due 2027 (the “Notes”) and instructed Wilmington Trust, National Association, as trustee under the indenture governing the Notes, to issue a redemption notice to registered holders of the Notes. The date fixed for the redemption of the Notes is October 11, 2024 (the “Redemption Dat…

The filing describes a stockholder approval of an equity incentive plan amendment, not a management change.

Results of Operations and Financial Condition. On May 9, 2024, Natera, Inc. issued a press release announcing the results for its first quarter ended March 31, 2024 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K and the accompanyin…

Results of Operations and Financial Condition. On February 28, 2024, Natera, Inc. issued a press release announcing the results for its fourth quarter and year ended December 31, 2023 and provided a related investor presentation. A copy of the press release and a copy of the investor presentation are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The information in this Current Report on Form 8-K…

Other Events. On January 22, 2024, Natera, Inc. (the “Company”) issued a press release announcing its acquisition of certain assets relating to Invitae Corporation’s non-invasive prenatal screening and genetic carrier screening business. A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.